Apellis Pharmaceuticals, Inc. — Form D/A

Apellis Pharmaceuticals, Inc. of CRESTWOOD, KY, a company, filed a Form D amendment with the SEC on 2011-06-20. The offering totals $4.2M, of which $3.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Marie-Claude BernalDirectorWellesley, MA
David DarstDirectorNew York, NY
Pascal DeschateletsDirectorCrestwood, KY
Sinclair DunlopDirectorBethesda, MD
Stephen GilliesDirectorWaltham, MA
Douglas OnsiDirectorCambridge, MA
Cedric FrancoisDirectorCrestwood, KY
Cedric FrancoisExecutive OfficerCrestwood, KY
Gerald ChanDirectorMonaco, O9
Alec MachielsDirectorNew York, NY
Bihua Sinclair ChenDirectorCrestwood, KY
Steven Sinclair AxonExecutive OfficerCrestwood, KY
Alec Sinclair MachielsDirectorCrestwood, KY
Stephanie Sinclair O'BrienDirectorNewton, MA
Robert Sinclair AdelmanDirectorCrestwood, KY
Nicole Sinclair PerryExecutive OfficerCrestwood, KY
Maha Sinclair KatabiDirectorCrestwood, KY
Gerald Sinclair ChanDirectorNewton, MA
A. Sinclair DunlopDirectorBethesda, MD
Daniel Sinclair GeffkenExecutive OfficerCrestwood, KY
Pascal DeschateletsExecutive OfficerCrestwood, KY
David Sinclair WatsonExecutive OfficerCrestwood, KY
Robert Sinclair KimExecutive OfficerCrestwood, KY
Stephanie O'BrienDirectorNewton, MA
Federico Sinclair GrossiExecutive OfficerCrestwood, KY

Other filings by this issuer (10)

FiledFormOfferingSold
2017-08-17D$60.1M$20.0M
2016-02-08D$47.1M$47.1M
2016-01-06D$32.1M$32.1M
2015-06-09D/A$17.7M$17.7M
2014-12-17D$21.5M$6.0M
2014-08-27D/A$24.0M$17.8M
2013-08-05D$8.0M$6.0M
2012-07-25D$3.0M$693K
2011-06-01D$4.2M$1.7M
2010-05-21D$6.0M$1.7M

More